ACTA1 and Myocardial fibrosis: In vivo studies indicated that BEL treatment ameliorated the cardiac disorder structure and myocardial fibrosis by inhibiting ISO-induced increases in α-SMA, collagen I, and collagen III while preventing collagen deposition in fibrotic tissues.